Breast cancer risk shows a transient increase in the years following pregnancy.1 While most tumors are estrogen receptor (ER) positive (+), the risk of ER negative (−) tumors with poorer prognosis2,3 remains elevated for decades after delivery as compared to nulliparous women.1,3. This evidence concerns the gene ESR1 and breast cancer.